Skip to content

Clinical trials

Obesity trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: South Korea Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20064
20072
20082
20092
20105
20115
20125
20132
20144
20156
20163
20178
20189
20195
20205
20219
202212
20238
20245
202511
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Recruiting21
Unknown status20
Active, not recruiting8
Terminated5
Enrolling by invitation4
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S16
Seoul National University Hospital12
Eli Lilly and Company10
Ajou University School of Medicine6
Amgen6
Chonbuk National University Hospital5
Glaceum5
Korea University5
Boehringer Ingelheim4
Korea University Anam Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity133
Overweight43
Diabetes Mellitus, Type 219
Metabolic Syndrome9
Diabetes Mellitus8
Atherosclerosis3
Body Weight Changes3
Heart Failure3
Arrhythmias, Cardiac2
Body Weight2

Trials

Showing 51 to 75 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.